Targeted disruption of hepatic frataxin expression causes impaired mitochondrial function, decreased life span and tumor growth in mice.

Thierbach R, Schulz TJ, Isken F, Voigt A, Mietzner B, Drewes G, von Kleist-Retzow JC, Wiesner RJ, Magnuson MA, Puccio H, Pfeiffer AF, Steinberg P, Ristow M
Hum Mol Genet. 2005 14 (24): 3857-64

PMID: 16278235 · DOI:10.1093/hmg/ddi410

We have disrupted expression of the mitochondrial Friedreich ataxia protein frataxin specifically in murine hepatocytes to generate mice with impaired mitochondrial function and decreased oxidative phosphorylation. These animals have a reduced life span and develop multiple hepatic tumors. Livers also show increased oxidative stress, impaired respiration and reduced ATP levels paralleled by reduced activity of iron-sulfur cluster (Fe/S) containing proteins (ISP), which all leads to increased hepatocyte turnover by promoting both apoptosis and proliferation. Accordingly, phosphorylation of the stress-inducible p38 MAP kinase was found to be specifically impaired following disruption of frataxin. Taken together, these findings indicate that frataxin may act as a mitochondrial tumor suppressor protein in mammals.

MeSH Terms (17)

Animals Apoptosis Cell Proliferation Hepatocytes Iron-Binding Proteins Iron-Sulfur Proteins Liver Liver Neoplasms Longevity Mice Mice, Inbred C57BL Mice, Knockout Mitochondria Oxidative Stress p38 Mitogen-Activated Protein Kinases Phosphorylation Reactive Oxygen Species

Connections (2)

This publication is referenced by other Labnodes entities: